Large-scale testing (Phase 3)WithdrawnNCT03242967
What this trial is testing
Study to Evaluate Three Times Per Week (TIW) Oral Dosing of Vadadustat for Anemia in Subjects With Dialysis-Dependent Chronic Kidney Disease (DD-CKD)
Who this might be right for
AnemiaDialysis-Dependent Chronic Kidney Disease
Akebia Therapeutics